BAUSCH + LOMB CORP (BLCO.CA) Stock Price, Forecast & Analysis
Canada • Toronto Stock Exchange • TSX:BLCO • CA0717051076
BLCO.CA Key Statistics, Chart & Performance
The current stock price of BLCO.CA is 23.25 CAD. In the past month the price decreased by -3.25%. In the past year, price increased by 1.09%.
BLCO.CA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to BLCO.CA. When comparing the yearly performance of all stocks, BLCO.CA is a bad performer in the overall market: 61.89% of all stocks are doing better.
BLCO.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA. BLCO.CA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
BLCO.CA Financial Highlights
Over the last trailing twelve months BLCO.CA reported a non-GAAP Earnings per Share(EPS) of 0.59. The EPS decreased by -29.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| Debt/Equity | 0.77 |
BLCO.CA Forecast & Estimates
19 analysts have analysed BLCO.CA and the average price target is 24.26 CAD. This implies a price increase of 4.34% is expected in the next year compared to the current price of 23.25.
For the next year, analysts expect an EPS growth of -10.8% and a revenue growth 6.46% for BLCO.CA
BLCO.CA Ownership
BLCO.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ZEN | ZENTEK LTD | N/A | 99.798M | ||
| OTC | OCUMETICS TECHNOLOGY CORP | N/A | 66.648M | ||
| COO | OSTROM CLIMATE SOLUTIONS INC | N/A | 4.564M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About BLCO.CA
Company Profile
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. The company is headquartered in Vaughan, Ontario and currently employs 13,500 full-time employees. The company went IPO on 2022-05-06. The company operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
Company Info
BAUSCH + LOMB CORP
520 Applewood Crescent
Vaughan ONTARIO CA
Employees: 13500
Phone: 19082552864
BAUSCH + LOMB CORP / BLCO.CA FAQ
What does BLCO do?
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. The company is headquartered in Vaughan, Ontario and currently employs 13,500 full-time employees. The company went IPO on 2022-05-06. The company operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
What is the stock price of BAUSCH + LOMB CORP today?
The current stock price of BLCO.CA is 23.25 CAD. The price increased by 3.56% in the last trading session.
What is the dividend status of BAUSCH + LOMB CORP?
BLCO.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of BLCO stock?
BLCO.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for BLCO.CA stock?
19 analysts have analysed BLCO.CA and the average price target is 24.26 CAD. This implies a price increase of 4.34% is expected in the next year compared to the current price of 23.25.